Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in Chemo-resistant, Recurrent or Metastatic Pancreatic Cancer
NCT03662412Phase 2Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jun 2018
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in pancreatic cancer (PC), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Status: unknown.
02
Drugs
sirolimus
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT03662412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03662412.